Filter
97
Filtered Results: 97
Text search:
heterologous
Featured
Recommendations
9
New Publications
14
Language
Document type
Guidelines
39
No document type
32
Studies & Reports
10
Manuals
5
Fact sheets
5
Strategic & Response Plan
4
Situation Updates
1
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
Latin America and the Carribbean
3
South Africa
3
Nigeria
2
Mozambique
2
Africa
2
Paraguay
2
Bolivia
2
Russia
2
Chile
1
Philippines
1
Tanzania
1
Germany
1
East and Southern Africa
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Guidelines
23
COVID-19
22
Rabies
4
Policies
3
Virology
2
Malaria
2
Paediatrics
1
Clinical Training
1
Hematology
1
Vaccine-preventable Diseases
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Studies & Reports
1
NTDs & Others
1
Dengue
1
Parasitology
1
Non-communicable Diseases
1
Disease Prevention & Control
1
Toolboxes
Country specific documents
13
Inactivated COVID-19 Vaccines
10
Booster Doses
9
Immunization Guidelines
8
Biontech/Pfizer Comirnaty
7
Vaxzevria (Astra Zeneca)
6
Moderna
4
Access & Strategy
3
Research & Access
3
Fair Allocation & Ethical Aspects
2
Johnson & Johnson
2
Covaxin
2
Clinical Aspects & Diagnostics
2
Zika
2
Laboratory & Diagnostics
2
Assessment & Studies
1
Vaccines & Immunization
1
Yellow Fever
1
Pediatrics
1
Dengue
1
HIV
1
TB
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Children/Adolescents Mental Disorders
1
Vaccination
1
Children
1
Clinical Guidelines
1
COVID-19
1
For Parents & Children
1
For Older People
1
Communication Material
1
Dashboards & Resource Platforms
1
SARS-CoV-2 Variants
1
Vector-based Vacines General
1
Sputnik V
1
Chile
1
Traditional & Herbal Medicines
1
Zoonoses
1
MPOX - Monkeypox
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
General Information & Methodology
1
Prevention & Strategies
1
Neurological Disorders
1
Food & Nutrition
1
Neurological disorders, Others
1
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
New edition
Rewiew Article
Hindawi Publishing Corporation, Tuberculosis Research and Treatment; Volume 2011, Article ID 712736, 6 pages, doi:10.1155/2011/712736
Review
Triccas and Counoupas Pneumonia (2016) 8:18; DOI 10.1186/s41479-016-0020-z
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinically relevant bacteria. Methods of specimen collection, transport, culture, anti-microbial drug suscept...
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
Lista Nacional de Medicamentos Esenciales
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
